Infections: Clinical Trials

2,512 trials for Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2512 completed. 2512 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42512Completed 2512

Follow Infections: new trials by email Literature Review of Infections trials Research Report on Infections

Trials (filtered) newest first · largest first

All 2,512 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intraperitoneal Hydrocortisone for Postoperative Pain and CRP Following Caesarean Section
hydrocortisone, Nornal Saline - Postoperative Pain, Caesarean Section
Phase 4CompletedRaditsya Mada Gautama, MD502026-06-252026-10-23
Efficacy and Safety of Oral Nicotinamide as an Adjunctive Therapy in Patients With Sepsis
Nicotinamide 1000 mg - Sepsis - to Reduce Mortality in the Intensive Care Unit
Phase 4CompletedAin Shams University602026-03-282026-10-20
Evaluation of the Anti-plaque Effect of a Bioflavonoid-based Antiseptic Mouthwash
Bioflavonoid mouthwash, Chlorhexidine 0.12% mouthwash - Gingival Inflammation, Dental Plaque Accumulation
Phase 4CompletedUniversity of Barcelona242026-03-022026-09-17
Comparison Between the Effect of Triclosan Toothpaste and Chlorhexidine Mouthwash on Gingival Health in a Group of Fixed Orthodontic Patients: A Randomized Controlled Clinical Trial
Triclosan 0.3% toothpaste, sodium fluoride 0.24% toothpaste, Chlorhexidine 0.2% mouthwash - Gingival Inflammation
Phase 4CompletedUniversity of Science and Technology, Yemen602026-02-142026-09-11
A Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of CANIUM Tab. in Acute Bronchitis Patients.
DSP2505(Canium), Umckamin, Placebo Matching Umckamin - Acute Bronchitis
Phase 4CompletedDasan Pharmaceutical Co., Ltd.2232026-01-262026-09-23
Evaluating the Effectiveness of Print Based Environmental Health Intervention Education Among School Going Adolescents of Karachi, A Quasi Study
Educational Intervention either from Poster or Infographic pamphlet - Environmental Health, Adolescent Health
Phase 4CompletedBahria University5002026-01-192026-04-30
Continuous Infusion Versus Intermittent Bolus Hydrocortisone in Septic Shock
Hydrocortisone Continuous Infusion, Hydrocortisone Intermittent Bolus - Septic Shock
Phase 4CompletedBenha University1102026-01-012026-07-10
Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19
mRNA-1273 (Moderna COVID-19 vaccine) - COVID-19
Phase 4CompletedTor Biering-Sørensen410602025-12-112026-10-06
Comparative Immunologic Mechanisms and Microbiome Interactions Following Different Influenza Vaccine Formulations in Older Adults
Standard-Dose Influenza Vaccine, MF59-Adjuvanted Influenza Vaccine, High-Dose Influenza Vaccine - Influenza, Influenza Vaccines
Phase 4CompletedKorea University Guro Hospital1212025-10-252026-09-04
Ultrasound-guided Combined Perineural and Intramuscular Dextrose Injection for Management of Refractory Bell's Palsy
Ultrasound-guided combined perineural and intramuscular dextrose injection. - Bell Palsy
Phase 4CompletedAl-Azhar University302025-10-102026-07-27
MAPS PrEP Van Study
Pre-Exposure Prophylaxis (PrEP) - HIV Infection
Phase 4CompletedDuke University72025-09-172026-07-24
Effect of Vitamin D as Adjuvant Therapy in Preterm Infants With Neonatal Sepsis
Vitamin D - Neonatal Sepsis, Preterm Infants
Phase 4CompletedUniversitas Padjadjaran782025-08-022026-02-05
Probiotics as an Adjunct to Antibiotics for Recurrent Bacterial Vaginosis
Probiotic Combination Cap/Tab, Placebo capsules - Recurrent Bacterial Vaginosis
Phase 4CompletedNishtar Medical University702025-08-012026-10-26
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
mRNA-1283.251 Variant-containing Formulation - COVID-19
Phase 4CompletedModernaTX, Inc.8322025-07-212026-07-07
Comparative Efficacy of Floss and Essential Oil/CPC+Zn Mouthwashes in Reducing Dental Plaque and Gingivitis
Mouthwash, Floss, Toothbrush - Dental Plaque, Gingivitis
Phase 4CompletedColgate Palmolive2282025-07-072025-10-30
Pooled Analysis of Methodologically Harmonized Pragmatic Randomized Trials of High-Dose vs. Standard-Dose Influenza Vaccine Against Severe Clinical Outcomes
High-Dose Influenza Vaccine, Standard-Dose Influenza Vaccine - Influenza
Phase 4CompletedTor Biering-Sørensen4663202025-05-312025-09-12
This Randomized Controlled Trial Evaluates the Comparative Efficacy of Intravenous Meropenem Alone Versus Intravenous Meropenem Combined With Oral Azithromycin in Children Aged 6 Months to Under 5 Years Diagnosed With Blood Culture-confirmed Extensively Drug-resistant Uncomplicated Typhoid Fever
Meropenem, Azithromycin + Metronidazole - Extensively Drug-Resistant Typhoid Fever, Typhoid Fever
Phase 4CompletedSheikh Zayed Medical College902025-05-142026-03-03
10-year Follow-up After a Single Dose Acellular Pertussis Vaccination
Pertagen® vaccine, Adacel® vaccine - Pertussis
Phase 4CompletedMahidol University902025-05-132026-10-08
CHAO Tos: Codeina, HederA Helix, LevOdropropizina Para la TOS
Codeine, Levodropropizine, Ivy Leaves Cough Liquid - Upper Resp Tract Infection
Phase 4CompletedPontificia Universidad Catolica de Chile1962025-05-132025-12-03
Decolonization Efficacy of Polyhexanide vs. Mupirocin
Polyhexanide, Mupirocin and Chlorhexidine - Staphylococcus Aureus, Colonization, Asymptomatic
Phase 4CompletedSwiss Paraplegic Research, Nottwil242025-05-012026-07-08

Showing 20 of 2512. Sign in to see all of them.

Narrower conditions

HIV Infections (299)  ·  Influenza, Human (266)  ·  Acquired Immunodeficiency Syndrome (138)  ·  COVID-19 (113)  ·  Malaria (111)  ·  Hepatitis C (109)  ·  Hepatitis C, Chronic (100)  ·  Hepatitis B (98)  ·  Hepatitis B, Chronic (85)  ·  Sepsis (70)  ·  Pneumonia (64)  ·  Surgical Wound Infection (51)  ·  Poliomyelitis (48)  ·  Tetanus (48)

Broader conditions

Virus Diseases (1329)  ·  RNA Virus Infections (1099)  ·  Communicable Diseases (779)  ·  Blood-Borne Infections (731)  ·  Pathological Conditions, Signs and Symptoms (701)  ·  Respiratory Tract Diseases (688)  ·  Respiratory Tract Infections (632)  ·  Pathologic Processes (608)  ·  Urogenital Diseases (561)  ·  Genital Diseases (481)  ·  Digestive System Diseases (456)  ·  Bacterial Infections and Mycoses (447)  ·  Immune System Diseases (447)  ·  Sexually Transmitted Diseases (431)

Interventions

Influenza Vaccines (111)  ·  Ribavirin (108)  ·  peginterferon alfa-2a (96)  ·  Tenofovir (69)  ·  Lamivudine (60)  ·  Artemether, Lumefantrine Drug Combination (51)  ·  Azithromycin (41)  ·  Ritonavir (41)  ·  Emtricitabine (38)  ·  Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (35)  ·  efavirenz (35)  ·  Amoxicillin (29)  ·  Vancomycin (29)  ·  Raltegravir Potassium (28)  ·  Lopinavir (27)

Sponsors

GlaxoSmithKline (109)  ·  Sanofi Pasteur, a Sanofi Company (60)  ·  Hoffmann-La Roche (56)  ·  Pfizer (38)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (37)  ·  Centers for Disease Control and Prevention (33)  ·  University of California, San Francisco (33)  ·  Sinovac Biotech Co., Ltd (25)  ·  Sanofi (24)  ·  London School of Hygiene and Tropical Medicine (22)  ·  Merck Sharp & Dohme LLC (21)  ·  Stanford University (19)  ·  University of Washington (19)  ·  Gilead Sciences (17)  ·  Duke University (16)

Countries

United States (712)  ·  China (203)  ·  Spain (143)  ·  Canada (118)  ·  United Kingdom (97)  ·  Germany (95)  ·  France (91)  ·  Brazil (83)  ·  Thailand (75)  ·  South Korea (71)  ·  Italy (65)  ·  Belgium (61)  ·  India (60)  ·  Taiwan (59)  ·  Australia (57)

Top investigators

Cornelia Dekker, MD (10)  ·  Stephen Quake, PhD (8)  ·  Xiaosong He, PhD (7)  ·  Chen-Hua Liu, MD (6)  ·  Cornelia L Dekker, MD (6)  ·  Konrad E Bloch, MD (6)

Results publications

PMID 39807668, PMID 32710245, PMID 38700045, PMID 28963118, PMID 22225814, PMID 25421474, PMID 29706550, PMID 33502773, PMID 35244208, PMID 41276263, PMID 41701614, PMID 18828899, PMID 20009522, PMID 21366801, PMID 21378375, PMID 21592984, PMID 22508412, PMID 22777097, PMID 23732904, PMID 24127770, PMID 24508042, PMID 24915612, PMID 25359354, PMID 25858004, PMID 26069949, PMID 26190091, PMID 26867206, PMID 28459966, PMID 28545923, PMID 28597967, PMID 30689258, PMID 30860013, PMID 31280481, PMID 31984244, PMID 32259266, PMID 32703235, PMID 32787892, PMID 33487470, PMID 33891293, PMID 35012490, PMID 35599306, PMID 36658045, PMID 37096802, PMID 37489818, PMID 37781954, PMID 37988391, PMID 39324693, PMID 39373164, PMID 40260835, PMID 41159585

NIH funding

2014 (14), 2015 (11), U19AI057229 (11), 2009 (9), 2019 (8), 2016 (6), 2017 (6), 2005 (5), 5UL1RR024982-02 (5), U19AI090019 (5), 2008 (4), U01AI068636 (4), 2004 (3), 2018 (3), R01AI145971 (2)